SRRK Scholar Rock Holding Corporation
Healthcare$51.51+7.02%ClosedMarket Cap: $6.17B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$59.17
Target (Median)
$59.00
Target Range
$55.00 - $65.00
Upside from current price: 14.9%
Rating Distribution
3 Strong Buy15 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Barclays | maintain | Overweight | Overweight |
| 2026-05-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-01 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-16 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-04 | Truist Securities | maintain | Buy | Buy |
| 2026-03-04 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-03-04 | BMO Capital | maintain | Outperform | Outperform |
| 2026-03-04 | Citigroup | maintain | Buy | Buy |
| 2026-03-04 | Barclays | maintain | Overweight | Overweight |
| 2026-03-03 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.49 | $156.1M | 13 |
| Sun Dec 31 | $-1.39 | $352.1M | 12 |
| Mon Dec 31 | $-0.24 | $560.1M | 10 |
| Tue Dec 31 | $1.38 | $837.5M | 5 |